Hormone modulating therapy may lower dementia risk in breast cancer survivors

[News]

Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published today in JAMA Network Open.

More... (https://www.news-medical.net/news/20240716/Hormone-modulating-therapy-may-lower-dementia-risk-in-breast-cancer-survivors.aspx)